Syndax Pharmaceuticals Inc short interest in 2024
In 2024, Syndax Pharmaceuticals Inc's disclosed short interest ran from 12.47% of shares outstanding on 12 Jan 2024 to 25.05% on 31 Dec 2024, a change of +12.58 percentage points. The year's high was 25.05% on 31 Dec 2024 and its low 9.82% on 28 Jun 2024, averaging 13.05% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 16.55 days on 30 Aug 2024. Full history: Syndax Pharmaceuticals Inc.
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 12.47% (12 Jan 2024)
- End of year
- 25.05% (31 Dec 2024)
- Change
- +12.58 pp
- High
- 25.05% (31 Dec 2024)
- Low
- 9.82% (28 Jun 2024)
- Average
- 13.05%
- Highest days to cover
- 16.55 (30 Aug 2024)
- SEC filings marked
- 8
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 12.47% | 7.32 | |
| 31 Jan 2024 | 12.47% | 6.83 | |
| 15 Feb 2024 | 12.35% | 7.99 | |
| 29 Feb 2024 | 13.05% | 8.74 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 11.96% | 6.08 | |
| 28 Mar 2024 | 13.81% | 8.17 | |
| 15 Apr 2024 | 13.79% | 10.92 | |
| 30 Apr 2024 | 14.52% | 11.22 | |
| 15 May 2024 | 11.80% | 10.67 | 10-Q filed, results (8-K) |
| 31 May 2024 | 11.35% | 9.54 | |
| 14 Jun 2024 | 11.67% | 8.83 | |
| 28 Jun 2024 | 9.82% | 5.85 | |
| 15 Jul 2024 | 10.03% | 9.26 | |
| 31 Jul 2024 | 10.09% | 7.64 | |
| 15 Aug 2024 | 11.09% | 9.02 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 11.16% | 16.55 | |
| 13 Sep 2024 | 11.36% | 8.13 | |
| 30 Sep 2024 | 11.85% | 8.25 | |
| 15 Oct 2024 | 12.35% | 14.31 | |
| 31 Oct 2024 | 12.52% | 16.34 | |
| 15 Nov 2024 | 12.46% | 4.05 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 16.92% | 6.63 | |
| 13 Dec 2024 | 19.23% | 8.07 | |
| 31 Dec 2024 | 25.05% | 6.77 |
See also: Syndax Pharmaceuticals Inc's full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.